www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

CB-839

Catalogue number:
CAY22038-5 mg
Supplier:
Size:
5 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£73.00 Estimated delivery Wed 24 Dec
Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

1439399-58-2

Purity:

≥98%

Formulation:

A crystalline solid

Molecular Formula:

C26H24F3N7O3S

Molecular Weight:

571.6

Alternative Names:

n-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide, gls1 inhibitor iii, telaglenastat

Product Description:

An orally bioavailable noncompetitive inhibitor of GLS1; inhibits GAC (IC50s 50s = 28 and 23 nM, respectively for brain and kidney) compared to GLS2 (IC50 > 1,000 nM for liver); antiproliferative against TNBC cell lines HCC1806 and MDA-MB-231 (IC50s = 49 and 26 nM, respectively), but not against estrogen receptor-positive cells T47D (IC50 > 1,000 nM); inhibits tumor growth by 61% in a patient-derived TNBC xenograft model (200 mg/kg, p.o.); antiproliferative against AML and in synergy with erlotinib against EGFR-driven NSCLC

CAY22038-5 mg: CB-839
CAY22038-5 mg: CB-839